| 1 | [SID49642929] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID49642929] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID49642929] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID49642929] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID49642929] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID49642929] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49642929] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 8 | [SID49642929] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID49642929] | Active | | | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex [AID2216, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex | | AID | 2216 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID49642929] | Active | AbsAC40_uM | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_Dose_CherryPick_Activity [AID651717, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | AbsAC40_uM | [uM] | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651717 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID49642929] | Active | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Active | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 12 | [SID49642929] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID49642929] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID49642929] | Inactive | Potency | 2.5929 | qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation [AID540253, Type: confirmatory] | snurportin-1 [Homo sapiens] [gi:5031833] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 2.5929 [uM] | | BioAssay | qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation | | AID | 540253 | | BioAssay type | confirmatory | | Target | snurportin-1 [Homo sapiens] [gi:5031833] | | PubMed | | | Data Table |  |
|
| 15 | [SID49642929] | Inactive | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID49642929] | Inactive | Potency | 18.526 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 18.526 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID49642929] | Inactive | Potency | 89.1251 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 18 | [SID49642929] | Inactive | Potency | 89.1251 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 19 | [SID49642929] | Inactive | Potency | 100 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 20 | [SID49642929] | Inactive | EC50 | 500 | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of the RanGTP-Importin-beta complex [AID2823, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | EC50 | 500 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of the RanGTP-Importin-beta complex | | AID | 2823 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID49642929] | Inactive | EC50 | 500 | Fluorescence Cell-Free Homogeneous Counterscreen to Identify Inhibitors of the RanGTP-Importin-beta complex. [AID435026, Type: confirmatory] | karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b [Homo sapiens] [gi:119609447] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | EC50 | 500 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Counterscreen to Identify Inhibitors of the RanGTP-Importin-beta complex. | | AID | 435026 | | BioAssay type | confirmatory | | Target | karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b [Homo sapiens] [gi:119609447] | | PubMed | | | Data Table |  |
|
| 22 | [SID49642929] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 23 | [SID49642929] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 24 | [SID49642929] | Inactive | Potency | | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding [AID2675, Type: confirmatory] | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding | | AID | 2675 | | BioAssay type | confirmatory | | Target | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] | | PubMed | | | Data Table |  |
|
| 25 | [SID49642929] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 26 | [SID49642929] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 27 | [SID49642929] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 28 | [SID49642929] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID49642929] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 30 | [SID49642929] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 31 | [SID49642929] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 32 | [SID49642929] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 33 | [SID49642929] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 34 | [SID49642929] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 35 | [SID49642929] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 36 | [SID49642929] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 37 | [SID49642929] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 38 | [SID49642929] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 39 | [SID49642929] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 40 | [SID49642929] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 41 | [SID49642929] | Inactive | Potency | | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 42 | [SID49642929] | Inactive | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 43 | [SID49642929] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 44 | [SID49642929] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 45 | [SID49642929] | Inactive | | | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay [AID651647, Type: screening] | MMP14 gene product [Homo sapiens] [gi:4826834] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay | | AID | 651647 | | BioAssay type | screening | | Target | MMP14 gene product [Homo sapiens] [gi:4826834] | | PubMed | | | Data Table |  |
|
| 46 | [SID49642929] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 47 | [SID49642929] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 48 | [SID49642929] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 49 | [SID49642929] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 50 | [SID49642929] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49642929 | | CID | 54684066 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|